A survey of bisphosphonate-related osteomyelitis/osteonecrosis of the jaws
Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-languag...
Saved in:
Published in | Japanese Journal of Oral and Maxillofacial Surgery Vol. 53; no. 10; pp. 594 - 602 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Japanese Society of Oral and Maxillofacial Surgeons
2007
|
Subjects | |
Online Access | Get full text |
ISSN | 0021-5163 2186-1579 |
DOI | 10.5794/jjoms.53.594 |
Cover
Abstract | Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-language literature. This report describes patients with bisphosphonate-related osteomyelitis and osteonecrosis of the jaws in Japan. The subjects were enrolled using questionnaires sent to 239 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2006. Thirty patients (4 men and 26 women) from 18 different institutions (mean age at diagnosis, 66.9 years) were studied. As for local features, pain with or without swelling was the most common symptom and sign. The mandible was affected in 22 patients, the maxilla in 6, and both jaws in 2. Twenty patients received intravenous bisphosphonates, 8 received only oral bisphosphonates, and 1 received both types of treatment. The reasons for bisphosphonate treatment were bone metastasis from breast carcinoma (13 patients), multiple myelomas (6 patients), osteoporosis (8 patients), and hypercalcemia related to malignancy. More than 50 % of the patients underwent oral surgery including tooth extraction just before or during treatment with bisphosphonates, while 5 patients received no dental treatment. In addition to antibiotic therapy, surgery, including sequestrectomy and curettage, was performed. As for outcome, 8 of the patients were completely cured, while 17 patients remained under treatment at the time of this writing. |
---|---|
AbstractList | Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis. Recently, a number of patients with bisphosphonate-associated osteomyelitis and osteonecrosis of the jaws have been reported in the English-language literature. This report describes patients with bisphosphonate-related osteomyelitis and osteonecrosis of the jaws in Japan. The subjects were enrolled using questionnaires sent to 239 institutions certified as training facilities by the Japanese Society of Oral and Maxillofacial Surgeons in 2006. Thirty patients (4 men and 26 women) from 18 different institutions (mean age at diagnosis, 66.9 years) were studied. As for local features, pain with or without swelling was the most common symptom and sign. The mandible was affected in 22 patients, the maxilla in 6, and both jaws in 2. Twenty patients received intravenous bisphosphonates, 8 received only oral bisphosphonates, and 1 received both types of treatment. The reasons for bisphosphonate treatment were bone metastasis from breast carcinoma (13 patients), multiple myelomas (6 patients), osteoporosis (8 patients), and hypercalcemia related to malignancy. More than 50 % of the patients underwent oral surgery including tooth extraction just before or during treatment with bisphosphonates, while 5 patients received no dental treatment. In addition to antibiotic therapy, surgery, including sequestrectomy and curettage, was performed. As for outcome, 8 of the patients were completely cured, while 17 patients remained under treatment at the time of this writing. |
Author | MORITA, Syosuke IMAI, Yutaka MIZUKI, Harumi SHIMADA, Jun SHIMAHARA, Masashi FURUSAWA, Kiyofumi UEYAMA, Yoshiya ARIYOSHI, Yasunori |
Author_xml | – sequence: 1 fullname: ARIYOSHI, Yasunori organization: Department of Dentistry and Oral Surgery, Division of Surgery 2, Osaka Medical College – sequence: 1 fullname: MORITA, Syosuke organization: First Department of Oral and Maxillofacial Surgery, Osaka Dental University – sequence: 1 fullname: FURUSAWA, Kiyofumi organization: Department of Oral and Maxillofacial Surgery, Matsumoto Dental University – sequence: 1 fullname: IMAI, Yutaka organization: Department of Oral and Maxillofacial Surgery, Dokkyo University School of Medicine – sequence: 1 fullname: SHIMADA, Jun organization: Division of First Oral and Maxillofacial Surgery, Department of Diagnosis and Therapeutics, Meikai University School of Dentistry – sequence: 1 fullname: UEYAMA, Yoshiya organization: Department of Oral and Maxillofacial Surgery, Yamaguchi University of Medicine – sequence: 1 fullname: SHIMAHARA, Masashi organization: Department of Dentistry and Oral Surgery, Division of Surgery 2, Osaka Medical College – sequence: 1 fullname: MIZUKI, Harumi organization: First Department of Oral and Maxillofacial Surgery, School of Dentistry, Iwate Medical University |
BookMark | eNp1kE1OwzAQhS1UJErpjgPkAKT43_GyqqCAKrGBdeS4E-oojSvbgHp7kgZYILGYGY3me0-jd4kmne8AoWuCF0Jpfts0fh8Xgi2E5mdoSkkhc9JfJmiKMSW5IJJdoHmMDcaYKE6p5FP0tMzie_iAY-brrHLxsPNDdSZBHqDtxzbzMYHfH6F1ycXb09aBDT66OKjSDrLGfMYrdF6bNsL8e87Q6_3dy-oh3zyvH1fLTW4p0zwHVnApt0ZpXROLQTBMtMK6KkxFGN1WllphKyxVjSuhBBS8kgJLqCnlteVshujoO7wQA9Sldckk57sUjGtLgsshkPIUSClY2QfSi27-iA7B7U04_oevR7yJybzBL2xCcraFESZaqkEwOIy9t_kh7M6EEjr2Bbs5f_s |
CitedBy_id | crossref_primary_10_2485_jhtb_22_141 crossref_primary_10_1016_j_jds_2022_10_030 crossref_primary_10_15214_jsodom_30_300 crossref_primary_10_1016_j_ajodo_2012_05_019 crossref_primary_10_3919_jjsa_70_1319 crossref_primary_10_3919_jjsa_69_3084 crossref_primary_10_1002_pds_3562 crossref_primary_10_1016_j_joms_2011_03_051 crossref_primary_10_2504_kds_64_208 crossref_primary_10_1016_j_joms_2018_04_009 crossref_primary_10_15214_jsodom_28_129 crossref_primary_10_1016_j_ajoms_2010_05_002 crossref_primary_10_5794_jjoms_55_354 |
ContentType | Journal Article |
Copyright | Japanese Society of Oral and Maxillofacial Surgeons |
Copyright_xml | – notice: Japanese Society of Oral and Maxillofacial Surgeons |
DBID | AAYXX CITATION |
DOI | 10.5794/jjoms.53.594 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
EISSN | 2186-1579 |
EndPage | 602 |
ExternalDocumentID | 10_5794_jjoms_53_594 article_jjoms1967_53_10_53_10_594_article_char_en |
GroupedDBID | ALMA_UNASSIGNED_HOLDINGS F5P JSF KQ8 RJT AAYXX CITATION |
ID | FETCH-LOGICAL-c2394-e38466da799f1c0e53019709b8ab132dbc2c5cb067f0b575e84b6506ef224fc43 |
ISSN | 0021-5163 |
IngestDate | Tue Jul 01 02:16:52 EDT 2025 Thu Apr 24 23:01:45 EDT 2025 Wed Sep 03 06:29:04 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c2394-e38466da799f1c0e53019709b8ab132dbc2c5cb067f0b575e84b6506ef224fc43 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/jjoms1967/53/10/53_10_594/_article/-char/en |
PageCount | 9 |
ParticipantIDs | crossref_citationtrail_10_5794_jjoms_53_594 crossref_primary_10_5794_jjoms_53_594 jstage_primary_article_jjoms1967_53_10_53_10_594_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2007 |
PublicationDateYYYYMMDD | 2007-01-01 |
PublicationDate_xml | – year: 2007 text: 2007 |
PublicationDecade | 2000 |
PublicationTitle | Japanese Journal of Oral and Maxillofacial Surgery |
PublicationTitleAlternate | Jpn. J. Oral. Maxillofac. Surg. |
PublicationYear | 2007 |
Publisher | Japanese Society of Oral and Maxillofacial Surgeons |
Publisher_xml | – name: Japanese Society of Oral and Maxillofacial Surgeons |
References | 15) Zarychanski, R., Elphee, E., et al.: Osteonecrosis of the jaw associated with Pamidronate therapy. Am J Hematol 81: 73-75 2006. 7) Marx, R. E., Sawatari, Y., et al.: Bisphosphonate-Induced exposed bone (Osteonecrosis/Osteoporosis) of the jaws: risk factor, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575 2005. 10) Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-375 2007. 20) Harper, R. P and Fung, E. F.: Resolution of Bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone (rhPTH (1-34). J Oral Maxillofac Surg 65: 573-580 2007. 1) Wang, J., Goodger, N. M., et al.: Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104-1107 2003. 8) Ficarra, G., Beninati, F., et al.: Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123-1128 2005. 2) Marx, R. E.: Pamidronate (Media) and Zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 61: 1115-1118 2003. 6) Ruggiero, S. L., Mehrotra, B., et al.: Osteonecrosis of the jaws associated with the use of Bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 62: 527-534 2004. 5) Thron, J. J., Hansen, H. S., et al.: Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 58: 1088 2000. 3) 高橋喜久雄, 川畑彰子, 他: ビスフォスフォネートによって発症したと考えられた上顎骨壊死の1例. 日口外誌 52: 416-419 2006. 14) Khamaisi, M., Regev, E., et al.: Possible association between diabetes and Bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92: 1172-1175 2007. 16) Bagan, J. V.: Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42: 327-329 2006. 17) Gibbs, S. D. J., Grady, J. O., et al.: Bisphosphonateinduced osteonecrosis of the jaw requires early detection and intervention. Med J Australia 183: 549-550 2005. 19) Merigo, E., Manfredi, M., et al.: Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613-617 2005. 13) Purcell, P. M. and Boyd, I. W.: Bisphosphonate and osteonecrosis of the jaw. Med J Australia 182: 417-418 2005. 11) Dunstan, C. R., Felsenberg, D., et al.: Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4: 42-55 2007. 9) Mavrokokki, T., Cheng, A., et al.: Nature and frequency of Bisphosphonate-Associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 65: 415-423 2007. 12) Farrugia, M. C., Summerlin, D. J., et al.: Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Larygoscope 116: 115-120 2006. 18) 浦出雅裕: ビスボスホネートと顎骨壊死. Clinical Calcium 17: 241-248 2007. 4) 岸直子, 足立忠文, 他: ビスフォスフォネートにより発症した下顎骨壊死の1例. 日口外誌 53: 28-32 2007. |
References_xml | – reference: 3) 高橋喜久雄, 川畑彰子, 他: ビスフォスフォネートによって発症したと考えられた上顎骨壊死の1例. 日口外誌 52: 416-419 2006. – reference: 18) 浦出雅裕: ビスボスホネートと顎骨壊死. Clinical Calcium 17: 241-248 2007. – reference: 14) Khamaisi, M., Regev, E., et al.: Possible association between diabetes and Bisphosphonate-related jaw osteonecrosis. J Clin Endocrinol Metab 92: 1172-1175 2007. – reference: 19) Merigo, E., Manfredi, M., et al.: Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report. J Oral Pathol Med 34: 613-617 2005. – reference: 5) Thron, J. J., Hansen, H. S., et al.: Osteoradionecrosis of the jaws: Clinical characteristics and relation to the field of irradiation. J Oral Maxillofac Surg. 58: 1088 2000. – reference: 12) Farrugia, M. C., Summerlin, D. J., et al.: Osteonecrosis of the mandible or maxilla associated with the use of new generation bisphosphonates. Larygoscope 116: 115-120 2006. – reference: 8) Ficarra, G., Beninati, F., et al.: Osteonecrosis of the jaws in periodontal patients with a history of bisphosphonates treatment. J Clin Periodontol 32: 1123-1128 2005. – reference: 11) Dunstan, C. R., Felsenberg, D., et al.: Therapy Insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease. Nat Clin Pract Oncol 4: 42-55 2007. – reference: 17) Gibbs, S. D. J., Grady, J. O., et al.: Bisphosphonateinduced osteonecrosis of the jaw requires early detection and intervention. Med J Australia 183: 549-550 2005. – reference: 15) Zarychanski, R., Elphee, E., et al.: Osteonecrosis of the jaw associated with Pamidronate therapy. Am J Hematol 81: 73-75 2006. – reference: 20) Harper, R. P and Fung, E. F.: Resolution of Bisphosphonate-associated osteonecrosis of the mandible: Possible application for intermittent low-dose parathyroid hormone (rhPTH (1-34). J Oral Maxillofac Surg 65: 573-580 2007. – reference: 10) Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws: American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the Jaws. J Oral Maxillofac Surg 65: 369-375 2007. – reference: 7) Marx, R. E., Sawatari, Y., et al.: Bisphosphonate-Induced exposed bone (Osteonecrosis/Osteoporosis) of the jaws: risk factor, recognition, prevention, and treatment. J Oral Maxillofac Surg 63: 1567-1575 2005. – reference: 2) Marx, R. E.: Pamidronate (Media) and Zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg. 61: 1115-1118 2003. – reference: 6) Ruggiero, S. L., Mehrotra, B., et al.: Osteonecrosis of the jaws associated with the use of Bisphosphonates: A review of 63 cases. J Oral Maxillofac Surg. 62: 527-534 2004. – reference: 9) Mavrokokki, T., Cheng, A., et al.: Nature and frequency of Bisphosphonate-Associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 65: 415-423 2007. – reference: 16) Bagan, J. V.: Jaw osteonecrosis associated with bisphosphonates: Multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral Oncol 42: 327-329 2006. – reference: 4) 岸直子, 足立忠文, 他: ビスフォスフォネートにより発症した下顎骨壊死の1例. 日口外誌 53: 28-32 2007. – reference: 13) Purcell, P. M. and Boyd, I. W.: Bisphosphonate and osteonecrosis of the jaw. Med J Australia 182: 417-418 2005. – reference: 1) Wang, J., Goodger, N. M., et al.: Osteonecrosis of the jaws associated with cancer chemotherapy. J Oral Maxillofac Surg 61: 1104-1107 2003. |
SSID | ssj0001742264 |
Score | 1.6185935 |
Snippet | Bisphosphonates are used for the management of bone metastatic disease and hypercalcemia caused by malignancy, as well as the treatment of osteoporosis.... |
SourceID | crossref jstage |
SourceType | Enrichment Source Index Database Publisher |
StartPage | 594 |
SubjectTerms | bisphosphonate bone metastasis jaw bones osteomyelitis osteonecrosis |
Title | A survey of bisphosphonate-related osteomyelitis/osteonecrosis of the jaws |
URI | https://www.jstage.jst.go.jp/article/jjoms1967/53/10/53_10_594/_article/-char/en |
Volume | 53 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Japanese Journal of Oral and Maxillofacial Surgery, 2007/10/20, Vol.53(10), pp.594-602 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Jj9MwFLbKwIELAgFi2JQDnKp0msTZbkSIqp1RqegihlNkO7amnbYZtQ2i_E3-EO_ZSaYRg2DgUKtNbcf1--q35C2EvIl8FQUBjW3G3cCmoWR2nAll0yxilMlYdCUa9Icfg_6Mnp77563WjwOvpWLHO-L7jXEl_0JVuAZ0xSjZW1C2nhQuwHugL7RAYWj_isZJe1tsvkr9kJzPt1cXOb7WID7aOkYFhEmM4chXe4lebkCynv68lsgcTSYSFDwXrBStKykVOChWpmwfiKujTZlVYMi-zZfLXDFtbJ8chFUjbsaDL6NJf6BPdrYt1vlmXtN0NB5ME21u3efb4rKGVG82nk2Sz_qrs_k-V8WqHjQYJmayYscuWcNGEV5zjmq9lQ_qH9bbNFGi-4jvlAeg1NewhJbt-KYATXWCm3TDFVK7B-exbyool6w90MHdv3ANmI0i11jkq23H9zr1oEYe7pLKqe4G51aY-l4KKlTZxjStemC8HMDzDrnrhqGDfqZnn6Jrw1-og5eN65H5fSYgA5dxcriIhqh0bwHaQuVpqIWf6UPyoISBlZhbPyItuX5MThPLwM_KlXUz_KwG_E4a4MNRAD4LwfeEzHofpu_7dlmawxauF1NbeiC3BhkL41g58H_2gU_EYTfmEeOO52ZcuMIXHEQh1eWgEciIctAFAqlAZFSCek_J0Rpu-IxYnvSFi3pHEAoqGWZnyryMKg6qfca63jFpV7uQijJvPZZPWepthz0zFEE6wJ4dk7d17yuTr-U3_d6ZDa173Zq-z_9_ihfkvnlWgCa9l-RotynkKxByd_y1Bs1PFCGyvQ |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+survey+of+bisphosphonate-related+osteomyelitis%2Fosteonecrosis+of+the+jaws&rft.jtitle=Japanese+Journal+of+Oral+and+Maxillofacial+Surgery&rft.au=ARIYOSHI%2C+Yasunori&rft.au=MORITA%2C+Syosuke&rft.au=FURUSAWA%2C+Kiyofumi&rft.au=IMAI%2C+Yutaka&rft.date=2007&rft.pub=Japanese+Society+of+Oral+and+Maxillofacial+Surgeons&rft.issn=0021-5163&rft.eissn=2186-1579&rft.volume=53&rft.issue=10&rft.spage=594&rft.epage=602&rft_id=info:doi/10.5794%2Fjjoms.53.594&rft.externalDocID=article_jjoms1967_53_10_53_10_594_article_char_en |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5163&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5163&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5163&client=summon |